WHO released the recommended components of seasonal influenza vaccine in the northern hemisphere for 2023-2024!
- Why are cancer patients prone to bone marrow suppression after chemotherapy?
- Johnson & Johnson’s New Direction in RSV Vaccine Development
- What Is the True Cause of Long COVID?
- New Cluster of Monkeypox Cases Reported in UK
- Could COVID-19 Be Accelerating Aging by Altering Our Genes?
- Air Pollution May Be a Trigger for Eczema
WHO released the recommended components of seasonal influenza vaccine in the northern hemisphere for 2023-2024!
- Nature: Unexpected Proteins Found in mRNA Vaccine Studies
- Deadly Fungus Found Across the U.S. with a 90% Fatality Rate!
- Sanofi Japan Data Breach: 730000 Healthcare Professionals’ Information Exposed
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
WHO released the recommended components of seasonal influenza vaccine in the northern hemisphere for 2023-2024!
Influenza is different from the common cold. It is caused by the latest influenza virus infection that mutates every year.
The symptoms are much more serious than the common cold. It will cause body aches, cough, runny nose, fever, etc., and may even directly lead to death. Vaccines have become a necessary means of preventing epidemic outbreaks.
The World Health Organization (WHO) predicts candidate influenza viruses in the northern and southern hemispheres every year, as a wind vane for vaccine production by vaccine companies.
On February 24, WHO officially released the recommended components of the 2023-2024 northern hemisphere seasonal influenza vaccine, so that countries and vaccine manufacturers can develop and produce influenza vaccines. Please note that there is an update for Type A strains!
Trivalent influenza vaccine strain components
Trivalent Chicken Embryo Vaccine
Virus of class A/Victoria/4897/2022 (H1N1)pdm09
Type A/Darwin/9/2021 (H3N2) virus
Class B/Austria/1359417/2021 virus (B/Victoria lineage)
Trivalent cell culture or recombinant protein vaccine
Class A/Wisconsin/67/2022 (H1N1)pdm09 virus
Type A/Darwin/6/2021 (H3N2) virus
Class B/Austria/1359417/2021 virus (B/Victoria lineage )
Quadrivalent influenza vaccine strain components
Quadrivalent chicken embryo culture vaccine
Virus of class A/Victoria/4897/2022 (H1N1)pdm09
Type A/Darwin/9/2021 (H3N2) virus
Class B/Austria/1359417/2021 virus (B/Victoria lineage)
Class B/Phuket/3073/2013 viruses (B/Yamagata lineage)
Quadrivalent cell culture or recombinant protein vaccine
Class A/Wisconsin/67/2022 (H1N1)pdm09 virus
Type A/Darwin/6/2021 (H3N2) virus
Class B/Austria/1359417/2021 virus (B/Victoria lineage )
Class B/Phuket/3073/2013 viruses (B/Yamagata lineage)
Reference:
https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2023-2024-northern-hemisphere-influenza-season
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
